Semiglazov VF - Search Results

1

More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin.

Berstein LM, Boyarkina MP, Tsyrlina EV, Turkevich EA, Semiglazov VF. Berstein LM, et al. Among authors: semiglazov vf. Med Oncol. 2011 Dec;28(4):1260-3. doi: 10.1007/s12032-010-9572-6. Epub 2010 May 20. Med Oncol. 2011. PMID: 20490716

2

Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects.

Berstein LM, Tsyrlina EV, Poroshina TE, Levina VV, Vasilyev DA, Kovalenko IG, Semiglazov VF. Berstein LM, et al. Among authors: semiglazov vf. Exp Oncol. 2006 Mar;28(1):64-9. Exp Oncol. 2006. PMID: 16614711

3

[Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives].

Bershteĭn LM, Boriakina MP, Turkevich EA, Tsyrlina EV, Semiglazov VF. Bershteĭn LM, et al. Among authors: semiglazov vf. Vopr Onkol. 2010;56(3):312-6. Vopr Onkol. 2010. PMID: 20804053 Russian.

4

Signs of proinflammatory/genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: role of menopausal status, estrogens and hyperglycemia.

Berstein LM, Kovalevskij AY, Poroshina TE, Kotov AV, Kovalenko IG, Tsyrlina EV, Leenman EE, Revskoy SY, Semiglazov VF, Pozharisski KM. Berstein LM, et al. Among authors: semiglazov vf. Int J Cancer. 2007 Aug 1;121(3):514-9. doi: 10.1002/ijc.22552. Int J Cancer. 2007. PMID: 17397026 Free article.

5

Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer.

Semiglazov VF, Semiglazov VV, Dashyan GA, Ziltsova EK, Ivanov VG, Bozhok AA, Melnikova OA, Paltuev RM, Kletzel A, Berstein LM. Semiglazov VF, et al. Among authors: semiglazov vv. Cancer. 2007 Jul 15;110(2):244-54. doi: 10.1002/cncr.22789. Cancer. 2007. PMID: 17538978 Free article. Clinical Trial.

6

Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients.

Berstein LM, Larionov AA, Kyshtoobaeva ASh, Pozharisski KM, Semiglazov VF, Ivanova OA. Berstein LM, et al. Among authors: semiglazov vf. J Cancer Res Clin Oncol. 1996;122(8):495-8. doi: 10.1007/BF01187162. J Cancer Res Clin Oncol. 1996. PMID: 8698750

7

Hormone-metabolic status in moderately smoking breast cancer patients.

Berstein LM, Tsyrlina EV, Semiglazov VF, Kovalenko IG, Gamayunova VB, Evtushenko TP, Ivanova OA. Berstein LM, et al. Among authors: semiglazov vf. Acta Oncol. 1997;36(2):137-40. doi: 10.3109/02841869709109221. Acta Oncol. 1997. PMID: 9140429

8

[Correlation between tumor tissue aromatase, histological pattern and reproductive status in patients with breast cancer].

Larionov AA, Uporov AV, Semiglazov VF, Berstein LM. Larionov AA, et al. Among authors: semiglazov vf. Vopr Onkol. 1998;44(1):37-42. Vopr Onkol. 1998. PMID: 9578729 Russian.

9

[Hormonal metabolic status in breast cancer patients after conservative surgery: comparison with known prognostic criteria].

Tsyrlina EV, Gamaiunova VB, Poroshina TE, Kovalenko IG, Semiglazov VF, Berstein LM. Tsyrlina EV, et al. Among authors: semiglazov vf. Vopr Onkol. 1999;45(3):261-4. Vopr Onkol. 1999. PMID: 10443228 Russian.

10

[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients].

Semiglazov VF, Ivanov VG, Gamaiunova VB, Zhil'tsova EK, Tsyrlina EV, Kovalenko IG, Bershteĭn LM. Semiglazov VF, et al. Vopr Onkol. 2001;47(4):425-7. Vopr Onkol. 2001. PMID: 11710283 Russian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page